Jun 17, 2025
Lisa Mcclain- Amount
- $1,001 to $15,000
- Filed
- Aug 13, 2025
Congress ticker disclosure profile
As of August 1 at 6:19 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference NBIX. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
28
Member filers
5
Disclosed ranges
$16K
Most active member desks
15 sells vs 13 buys
Latest trade Jun 17, 2025
Jun 17, 2025
Lisa McclainJun 11, 2025
Lisa McclainNov 19, 2024
Michael T. McCaulAug 26, 2024
Michael T. McCaulOct 27, 2023
Michael T. McCaulAug 14, 2023
Michael T. McCaulMay 2, 2023
Michael T. McCaulFeb 10, 2023
Ro KhannaDec 16, 2022
Michael T. McCaulDec 6, 2022
Ro KhannaJan 28, 2022
Michael T. McCaulDec 21, 2021
Michael T. McCaulDec 14, 2021
Michael T. McCaulJun 24, 2021
Michael T. McCaulMar 9, 2021
Michael T. McCaulDec 21, 2020
Gilbert CisnerosNov 12, 2020
Michael T. McCaulOct 1, 2020
Michael T. McCaulJul 21, 2020
Gilbert CisnerosMar 2, 2020
Michael T. McCaulDec 12, 2019
Michael T. McCaulJan 18, 2019
Michael T. McCaulJan 17, 2019
Michael T. McCaulJan 16, 2019
Michael T. McCaulJan 15, 2019
Michael T. McCaulDec 17, 2018
Ro KhannaDec 13, 2018
Josh GottheimerApr 3, 2018
Ro Khanna| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jun 17, 2025 | Lisa Mcclain | Sell | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Jun 11, 2025 | Lisa Mcclain | Buy | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Nov 19, 2024 | Michael T. McCaul | Sell | Receipt pending ingestion | Dec 16, 2024 | Open card |
| Aug 26, 2024 | Michael T. McCaul | Sell | Receipt pending ingestion | Sep 16, 2024 | Open card |
| Oct 27, 2023 | Michael T. McCaul | Sell | Receipt pending ingestion | Nov 13, 2023 | Open card |
| Aug 14, 2023 | Michael T. McCaul | Buy | Receipt pending ingestion | Sep 14, 2023 | Open card |
| May 2, 2023 | Michael T. McCaul | Sell | Receipt pending ingestion | Jun 22, 2023 | Open card |
| Feb 10, 2023 | Ro Khanna | Sell | Receipt pending ingestion | Mar 3, 2023 | Open card |
| Dec 16, 2022 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 19, 2023 | Open card |
| Dec 6, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jan 6, 2023 | Open card |
| Jan 28, 2022 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 23, 2022 | Open card |
| Dec 21, 2021 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 27, 2022 | Open card |
| Dec 14, 2021 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 27, 2022 | Open card |
| Jun 24, 2021 | Michael T. McCaul | Buy | Receipt pending ingestion | Jul 16, 2021 | Open card |
| Mar 9, 2021 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 19, 2021 | Open card |
| Dec 21, 2020 | Gilbert Cisneros | Buy | Receipt pending ingestion | Jan 11, 2021 | Open card |
| Nov 12, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Jan 7, 2021 | Open card |
| Oct 1, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | Nov 30, 2020 | Open card |
| Jul 21, 2020 | Gilbert Cisneros | Sell | Receipt pending ingestion | Aug 19, 2020 | Open card |
| Mar 2, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Dec 12, 2019 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 29, 2020 | Open card |
| Jan 18, 2019 | Michael T. McCaul | Buy | Receipt pending ingestion | Feb 25, 2019 | Open card |
| Jan 17, 2019 | Michael T. McCaul | Buy | Receipt pending ingestion | Feb 25, 2019 | Open card |
| Jan 16, 2019 | Michael T. McCaul | Buy | Receipt pending ingestion | Feb 25, 2019 | Open card |
| Jan 15, 2019 | Michael T. McCaul | Buy | Receipt pending ingestion | Feb 25, 2019 | Open card |
| Dec 17, 2018 | Ro Khanna | Sell | Receipt pending ingestion | Jan 11, 2019 | Open card |
| Dec 13, 2018 | Josh Gottheimer | Sell | Receipt pending ingestion | Jan 4, 2019 | Open card |
| Apr 3, 2018 | Ro Khanna | Buy | Receipt pending ingestion | May 10, 2018 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 2 of 28 filed rows include disclosed amount ranges (7.1%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.